Frank Barry gives keynote presentation at Zoobiquity Colorado meeting

On October 5 and 6, 2018, Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine will take place. Here, ADIPOA-2 Coordinator Prof Frank Barry of the Regenerative Medicine Institute at the National University of Ireland Galway will deliver a keynote presentation, ‘Cell Strategies for Arthritic Disease’.

Zoobiquity Colorado aims to uncover the astonishing connection between human and animal health by highlighting laboratory and clinical research of human and veterinary investigators and fostering future collaboration across disciplines.

Cell and Gene Therapy Industry Forum in Galway addresses opportunities for innovation

Leaders in industry and science met and discussed recent advances in cell and gene therapy research and development at an industry-focused event held on Thursday, June 28, 2018, at the Meyrick Hotel in Galway, Ireland.  Industry representation included presentations from Takeda, ReNeuron, Avectas and Valitacell. ADIPOA-2 Coordinator Prof Frank Barry presented the project’s mission, progress and innovative aspects.

The emerging fields of cell and gene therapy are considered by many to be the next revolution in medicine, promising unprecedented and previously unimaginable treatments for major life-altering conditions and degenerative diseases. There are few areas of biomedical research which have attracted so much attention in recent years and been surrounded by so much expectation and promise. However, serious challenges remain in addressing manufacturing efficiency, cost reduction, clinical trials and delivery to patients.

The event sponsors were The Celtic Advanced Life Science Innovation Network, an Ireland Wales 2014-2020 programme partially funded by the European Regional Development Fund through the Welsh Government.

Speakers included: Robin Ali, University College London, Frank Barry REMEDI at NUI Galway, John Sinden, ReNeuron, Michael McGuire Avectas, Andrew Finnerty CCMI, Maria del Pilar Redondo, Takeda Europe, Mary Murphy REMEDI at NUI Galway, Stephanie Davis Valitacell and Gerry McCauliffe of Omnispirant.

Read the entire event programme: CALIN Galway Programme. 

ADIPOA-2 will present at EU-MSC2 meeting in Leiden in September

Hosted by Leiden University Medical Center, the EU MSC2 2017 meeting in Leiden, NL on September 12th and 13th will assemble twelve EU-funded, mesenchymal stromal cell-focussed consortia. Projects to be presented include: REDDSTARREACH, NephstromSCIENCEVISICORT and Adipoa-2AUTOSTEMBOOSTB4, SEPCELL, RESSTORE,  RETHRIM, Stellar, MERLIN, and RESPINE. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden. Three overarching aspects of the EU-MSC2 meeting include: mechanisms of action and potency assays; an interactive panel discussion on product development, and product development and market authorisation in a changing regulatory landscape.

The objectives of the meeting are to:

  • Enhance knowledge-sharing between EU research groups working in the mesenchymal stromal cell biology domain
  • Engage with European Commission Project Officers and other stakeholders from International Society of Cellular Therapy, stem cell ethicists and the European Medicines Agency (EMA)
  • Assemble trans-disciplinary research groups working across the global health spectrum but with a common focus of mesenchymal stromal cell biology
  • Bring up-and-coming researchers together for networking purposes, and to explore future consortium building and international funding application opportunities

Expected impacts and outcomes:

  • Provide opportunities to develop new mesenchymal stromal cell networks
  • Disseminate the findings and challenges between MSC-focussed consortia
  • Improve the communication potential of research, outcomes and the value of the research
  • Explore potential for new commercial technologies
  • Collectively enhance the quality and impact of planned clinical trials

These EU-funded projects are:

  • Improving the quality of life for European citizens
  • Progressing the clinical translation of MSC research and developments

For more information, please visit EU MSC2 2017.
Register via Eventbrite by August 14 2017.
Read the EU-MSC2 2015 meeting report here.